Dimensional Fund Advisors LP Scynexis Inc Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$1.56 - $2.24 $7,781 - $11,173
4,988 Added 49.84%
14,997 $33,000
Q3 2023

Nov 09, 2023
BUY
$1.93 - $3.64 $19,317 - $36,432
10,009 New
10,009 $22,000
Q4 2022

Feb 09, 2023
SELL
$1.46 - $2.94 $7,197 - $14,494
-4,930 Reduced 28.99%
12,076 $18,000
Q3 2022

Nov 10, 2022
BUY
$1.83 - $2.93 $31,120 - $49,827
17,006 New
17,006 $41,000

Others Institutions Holding SCYX

# of Institutions
48
Shares Held
13.7M
Call Options Held
21.9K
Put Options Held
2.6K
View Full List

About SCYNEXIS INC

SCYX Quotes by TradingView
  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email